Concepedia

Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men

Stephanie Popping, Sebastiaan Hullegie, Anne Boerekamps, Bart Rijnders, Robert J. de Knegt, Jürgen K. Rockstroh, Annelies Verbon, Charles A. Boucher, Brooke E Nichols, David van de Vijver

PLoS ONE · 2019 · 36 citations · 43 references

DOIFull text

Open access

Abstract

Early DAA treatment for HIV-infected MSM is an excellent and sustainable tool to meet the WHO goal of eliminating HCV in 2030.

References

43

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

, , +4

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

EASL Recommendations on Treatment of Hepatitis C 2016

Journal of Hepatology · 2016 · 976 citations

, , +4

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Michael P. Curry, Jacqueline G. O’Leary, Natalie Bzowej et al. · New England Journal of Medicine · 2015 · 795 citations · Full text

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆

Angelo Sangiovanni, E. Del Ninno, Pierangelo Fasani et al. · Gastroenterology · 2004 · 606 citations · Full text